Form D Explorer

Form C/A — iMetabolic Biopharma Corporation

0001665160-23-000414 · filed 2023-03-15 · via StartEngine Capital, LLC

Offering

Target: $10,000
Maximum: $1,230,000
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: iMetabolic Biopharma Corporation
CIK: 1957114
Entity: Corporation
Jurisdiction: NV
Address: 2155 E Conference Dr
Tempe, AZ 85284-2604
Phone: —

Most recent fiscal year financials

Total assets

$64,248

Cash

—

Short-term debt

$17,192

Long-term debt

$139,336

Revenues

—

COGS

—

Taxes paid

—

Net income

$-63,745

View original on SEC EDGAR.